Dorman A M, Chin D, Leader M
Department of Pathology, Royal College of Surgeons, Ireland.
J Clin Pathol. 1992 Oct;45(10):932-3. doi: 10.1136/jcp.45.10.932.
Sections (5 microns thick) from 101 primary adenocarcinomas (including ovarian, colorectal, gastric, breast, oesophageal, prostatic, pancreatic, endometrial and gall bladder) were incubated wtih anticolon specific antigen (CSA) and anticolon ovarian tumour antigen (COTA) antibodies using the peroxidase antiperoxidase technique with positive and negative controls. Anti-CSA positivity was seen in 19 of 20 colonic adenocarcinomas, but it was also seen in a large number of the other tumours. While anti-COTA staining was positive in 16 of 20 colonic adenocarcinomas and 20 of 30 ovarian adenocarcinomas, it was also positive in a large number of the tumours. Anti-CSA and anti-COTA are not adequately specific in the identification of a colonic or ovarian origin of an adenocarcinoma and cannot reliably be applied to the identification of a metastatic adenocarcinoma of unknown primary site.
使用过氧化物酶抗过氧化物酶技术及阳性和阴性对照,将取自101例原发性腺癌(包括卵巢癌、结直肠癌、胃癌、乳腺癌、食管癌、前列腺癌、胰腺癌、子宫内膜癌和胆囊癌)的切片(5微米厚)与抗结肠特异性抗原(CSA)和抗结肠卵巢肿瘤抗原(COTA)抗体进行孵育。在20例结肠腺癌中有19例抗CSA呈阳性,但在大量其他肿瘤中也可见到。抗COTA染色在20例结肠腺癌中的16例以及30例卵巢腺癌中的20例呈阳性,在大量肿瘤中也呈阳性。抗CSA和抗COTA在鉴定腺癌的结肠或卵巢起源方面特异性不足,不能可靠地用于鉴定原发部位不明的转移性腺癌。